A “minimalist” approach to transfemoral valve-in-valve transcatheter mitral valve replacement (TMVR), not unlike the approach commonly used with TAVI, appears to be safe and feasible when compared ...

Tampa General is one of just five health care institutions in the nation to offer AltaValve as an alternative to open-heart surgery. TAMPA, Fla., Jan. 30, 2024 /PRNewswire/ -- Tampa General Hospital ...

Piedmont Heart Institute (PHI) physicians Pradeep K. Yadav, M.D., Director of Structural Interventions, and Vinod H. Thourani, M.D., Marcus Chairman of Cardiovascular Surgery, successfully performed ...

Preemptive alcohol septal ablation appears to lower the risk of life-threatening left ventricular outflow tract (LVOT) obstruction in select patients undergoing transcatheter mitral valve replacement ...

The transcatheter mitral valve replacement (TMVR) market is projected to grow at a CAGR of 20% over the forecast period. Major factors driving growth include increased prevalence of mitral valve ...

NeoChord, Inc. (“NeoChord”) announced on October 4, 2021 that it successfully completed a first-in-human procedure with the NeXuS Transcatheter Mitral Chordal Repair (TMVr) device NeoChord is ...

Abbott Laboratories has received approval for a mitral valve replacement that can be implanted without open-heart surgery. The U.S. Food & Drug Administration gave the OK for the North Chicago-based ...

Edwards Lifesciences announced Thursday that the California company has completed three first-in-human implants of the company’s transcatheter mitral valve replacement system. But it is not the only ...

LOS GATOS, Calif., Oct. 23, 2024 /PRNewswire/ -- Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced today the first-in-human trans-septal implantations using the 28 Fr. (French) Luna™ ...

Tampa General is one of just five health care institutions in the nation to offer AltaValve as an alternative to open-heart surgery. "At Tampa General, we're pioneering new technologies that can save ...